Literature DB >> 17043769

Molecular mechanisms of GD3-induced apoptosis in U-1242 MG glioma cells.

O M Omran1, H E Saqr, Allan J Yates.   

Abstract

An increasing amount of evidence indicates that the disialoganglioside GD3 is involved in apoptosis in many cell lines. Our previous studies demonstrated that endogenous GD3 expression induced apoptosis in U-1242 MG glioma cells transfected with the GD3 synthase gene (U1242MG-GD3 cells). In this paper, we present further investigations on the molecular mechanisms of GD3-induced apoptosis in this cell line. We found that endogenously synthesized GD3 localizes to the caveolae of this cell line, where it promotes the localization of death receptor 5 (DR5), tumor necrosis factor receptor-1 (TNF-R1), and Fas (Apo-1) to the caveolae. In addition, caspase-8 was translocated to the caveolar fraction and cleaved; the cleaved proteins were then re-located into the high density fractions. However, GD3 had no effect on the distribution of the adapter protein Fas-associated death domain (FADD). We conclude that GD3 functions as a regulatory molecule early in the extrinsic apoptosis pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17043769     DOI: 10.1007/s11064-006-9147-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

1.  c-Jun NH2-terminal kinase activation leads to a FADD-dependent but Fas ligand-independent cell death in Jurkat T cells.

Authors:  Y Chen; M Z Lai
Journal:  J Biol Chem       Date:  2000-12-05       Impact factor: 5.157

2.  GD3 recruits reactive oxygen species to induce cell proliferation and apoptosis in human aortic smooth muscle cells.

Authors:  Anil Kumar Bhunia; Gunter Schwarzmann; Subroto Chatterjee
Journal:  J Biol Chem       Date:  2002-02-22       Impact factor: 5.157

3.  Diagnostic and prognostic value of glycosyltransferase mRNA in glioblastoma multiforme patients.

Authors:  J L Oblinger; D K Pearl; C L Boardman; H Saqr; T W Prior; B W Scheithauer; R B Jenkins; P C Burger; A J Yates
Journal:  Neuropathol Appl Neurobiol       Date:  2006-08       Impact factor: 8.090

4.  Gangliosides inhibit platelet-derived growth factor-stimulated growth, receptor phosphorylation, and dimerization in neuroblastoma SH-SY5Y cells.

Authors:  D L Hynds; M Summers; J Van Brocklyn; M S O'Dorisio; A J Yates
Journal:  J Neurochem       Date:  1995-11       Impact factor: 5.372

5.  Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation.

Authors:  E G Bremer; S Hakomori; D F Bowen-Pope; E Raines; R Ross
Journal:  J Biol Chem       Date:  1984-06-10       Impact factor: 5.157

6.  Occurrence of GD3 ganglioside in reactive astrocytes--an immunocytochemical study in the rat brain.

Authors:  K Kawai; S Kuroda; S Watarai; H Takahashi; F Ikuta
Journal:  Neurosci Lett       Date:  1994-06-20       Impact factor: 3.046

7.  Disialoganglioside GD3 is released by microglia and induces oligodendrocyte apoptosis.

Authors:  B M Simon; F Malisan; R Testi; P Nicotera; M Leist
Journal:  Cell Death Differ       Date:  2002-07       Impact factor: 15.828

8.  Correlation of ganglioside patterns of primary brain tumors with survival.

Authors:  C C Sung; D K Pearl; S W Coons; B W Scheithauer; P C Johnson; M Zheng; A J Yates
Journal:  Cancer       Date:  1995-02-01       Impact factor: 6.860

9.  Cellular distribution of gangliosides in the developing mouse cerebellum: analysis using the staggerer mutant.

Authors:  T N Seyfried; D J Bernard; R K Yu
Journal:  J Neurochem       Date:  1984-10       Impact factor: 5.372

10.  Gangliosides inhibit platelet-derived growth factor-stimulated receptor dimerization in human glioma U-1242MG and Swiss 3T3 cells.

Authors:  J Van Brocklyn; E G Bremer; A J Yates
Journal:  J Neurochem       Date:  1993-07       Impact factor: 5.372

View more
  3 in total

1.  Targeting the GD3 acetylation pathway selectively induces apoptosis in glioblastoma.

Authors:  Suzanne M Birks; John Owusu Danquah; Linda King; Reinhardt Vlasak; Dariusz C Gorecki; Geoffrey J Pilkington
Journal:  Neuro Oncol       Date:  2011-07-31       Impact factor: 12.300

Review 2.  Podocyte pathology and nephropathy - sphingolipids in glomerular diseases.

Authors:  Sandra Merscher; Alessia Fornoni
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-30       Impact factor: 5.555

Review 3.  Re-configuration of sphingolipid metabolism by oncogenic transformation.

Authors:  Anthony S Don; Xin Y Lim; Timothy A Couttas
Journal:  Biomolecules       Date:  2014-03-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.